Cargando…
Adherence to oral anticancer chemotherapy: What influences patients’ over or non-adherence? Analysis of the OCTO study through quantitative–qualitative methods
BACKGROUND: Numerous oral anticancer chemotherapies are available. Non-adherence or over-adherence to these chemotherapies can lead to lowered efficacy and increased risk of adverse events. The objective of this study was to identify patients’ adherence profiles using a qualitative–quantitative meth...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490730/ https://www.ncbi.nlm.nih.gov/pubmed/26142140 http://dx.doi.org/10.1186/s13104-015-1231-8 |
_version_ | 1782379561055420416 |
---|---|
author | Bourmaud, Aurélie Henin, Emilie Tinquaut, Fabien Regnier, Véronique Hamant, Chloé Colomban, Olivier You, Benoit Ranchon, Florence Guitton, Jérôme Girard, Pascal Freyer, Gilles Tod, Michel Rioufol, Catherine Trillet-Lenoir, Véronique Chauvin, Franck |
author_facet | Bourmaud, Aurélie Henin, Emilie Tinquaut, Fabien Regnier, Véronique Hamant, Chloé Colomban, Olivier You, Benoit Ranchon, Florence Guitton, Jérôme Girard, Pascal Freyer, Gilles Tod, Michel Rioufol, Catherine Trillet-Lenoir, Véronique Chauvin, Franck |
author_sort | Bourmaud, Aurélie |
collection | PubMed |
description | BACKGROUND: Numerous oral anticancer chemotherapies are available. Non-adherence or over-adherence to these chemotherapies can lead to lowered efficacy and increased risk of adverse events. The objective of this study was to identify patients’ adherence profiles using a qualitative–quantitative method. METHODS: A capecitabine treatment was initiated for 38 patients with advanced breast or colorectal cancer. At inclusion, information on patients’ beliefs was reported using a questionnaire. Later, Information on patients’ relation to treatment was obtained from a sub-group during an interview with a sociologist. Questionnaires were analyzed using Multiple Classification Analysis to cluster patients. Treatment adherence was evaluated by an electronic medication event monitoring systems (MEMS caps) and then correlated with patient clusters. Interviews were analyzed to complete and explain results. RESULTS: 38 patients were enrolled between 2008 and 2011 and completed the questionnaire. Twenty had adherence measured with MEMS caps all along treatment. Between 4 and 6 months after inclusion, 16 patients were interviewed. Patient profile B (retired, with a regular life, surrounded by a relative’s attention to drug adherence, with a low educational level) was statistically associated with adequate adherence (p = 0.049). A tendency for lower adherence was observed among more highly educated patients with an irregular, active life (NS). All patients taking capecitabine demonstrated a risk of over-adherence, potentiating side effects. CONCLUSIONS: These encouraging primary results suggest that further studies should be undertaken and that educational programs tailored to patient profiles should be evaluated to enhance adherence for those who need it and to empower all patients to manage treatment side effects. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13104-015-1231-8) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4490730 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-44907302015-07-04 Adherence to oral anticancer chemotherapy: What influences patients’ over or non-adherence? Analysis of the OCTO study through quantitative–qualitative methods Bourmaud, Aurélie Henin, Emilie Tinquaut, Fabien Regnier, Véronique Hamant, Chloé Colomban, Olivier You, Benoit Ranchon, Florence Guitton, Jérôme Girard, Pascal Freyer, Gilles Tod, Michel Rioufol, Catherine Trillet-Lenoir, Véronique Chauvin, Franck BMC Res Notes Research Article BACKGROUND: Numerous oral anticancer chemotherapies are available. Non-adherence or over-adherence to these chemotherapies can lead to lowered efficacy and increased risk of adverse events. The objective of this study was to identify patients’ adherence profiles using a qualitative–quantitative method. METHODS: A capecitabine treatment was initiated for 38 patients with advanced breast or colorectal cancer. At inclusion, information on patients’ beliefs was reported using a questionnaire. Later, Information on patients’ relation to treatment was obtained from a sub-group during an interview with a sociologist. Questionnaires were analyzed using Multiple Classification Analysis to cluster patients. Treatment adherence was evaluated by an electronic medication event monitoring systems (MEMS caps) and then correlated with patient clusters. Interviews were analyzed to complete and explain results. RESULTS: 38 patients were enrolled between 2008 and 2011 and completed the questionnaire. Twenty had adherence measured with MEMS caps all along treatment. Between 4 and 6 months after inclusion, 16 patients were interviewed. Patient profile B (retired, with a regular life, surrounded by a relative’s attention to drug adherence, with a low educational level) was statistically associated with adequate adherence (p = 0.049). A tendency for lower adherence was observed among more highly educated patients with an irregular, active life (NS). All patients taking capecitabine demonstrated a risk of over-adherence, potentiating side effects. CONCLUSIONS: These encouraging primary results suggest that further studies should be undertaken and that educational programs tailored to patient profiles should be evaluated to enhance adherence for those who need it and to empower all patients to manage treatment side effects. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13104-015-1231-8) contains supplementary material, which is available to authorized users. BioMed Central 2015-07-04 /pmc/articles/PMC4490730/ /pubmed/26142140 http://dx.doi.org/10.1186/s13104-015-1231-8 Text en © Bourmaud et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Bourmaud, Aurélie Henin, Emilie Tinquaut, Fabien Regnier, Véronique Hamant, Chloé Colomban, Olivier You, Benoit Ranchon, Florence Guitton, Jérôme Girard, Pascal Freyer, Gilles Tod, Michel Rioufol, Catherine Trillet-Lenoir, Véronique Chauvin, Franck Adherence to oral anticancer chemotherapy: What influences patients’ over or non-adherence? Analysis of the OCTO study through quantitative–qualitative methods |
title | Adherence to oral anticancer chemotherapy: What influences patients’ over or non-adherence? Analysis of the OCTO study through quantitative–qualitative methods |
title_full | Adherence to oral anticancer chemotherapy: What influences patients’ over or non-adherence? Analysis of the OCTO study through quantitative–qualitative methods |
title_fullStr | Adherence to oral anticancer chemotherapy: What influences patients’ over or non-adherence? Analysis of the OCTO study through quantitative–qualitative methods |
title_full_unstemmed | Adherence to oral anticancer chemotherapy: What influences patients’ over or non-adherence? Analysis of the OCTO study through quantitative–qualitative methods |
title_short | Adherence to oral anticancer chemotherapy: What influences patients’ over or non-adherence? Analysis of the OCTO study through quantitative–qualitative methods |
title_sort | adherence to oral anticancer chemotherapy: what influences patients’ over or non-adherence? analysis of the octo study through quantitative–qualitative methods |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490730/ https://www.ncbi.nlm.nih.gov/pubmed/26142140 http://dx.doi.org/10.1186/s13104-015-1231-8 |
work_keys_str_mv | AT bourmaudaurelie adherencetooralanticancerchemotherapywhatinfluencespatientsoverornonadherenceanalysisoftheoctostudythroughquantitativequalitativemethods AT heninemilie adherencetooralanticancerchemotherapywhatinfluencespatientsoverornonadherenceanalysisoftheoctostudythroughquantitativequalitativemethods AT tinquautfabien adherencetooralanticancerchemotherapywhatinfluencespatientsoverornonadherenceanalysisoftheoctostudythroughquantitativequalitativemethods AT regnierveronique adherencetooralanticancerchemotherapywhatinfluencespatientsoverornonadherenceanalysisoftheoctostudythroughquantitativequalitativemethods AT hamantchloe adherencetooralanticancerchemotherapywhatinfluencespatientsoverornonadherenceanalysisoftheoctostudythroughquantitativequalitativemethods AT colombanolivier adherencetooralanticancerchemotherapywhatinfluencespatientsoverornonadherenceanalysisoftheoctostudythroughquantitativequalitativemethods AT youbenoit adherencetooralanticancerchemotherapywhatinfluencespatientsoverornonadherenceanalysisoftheoctostudythroughquantitativequalitativemethods AT ranchonflorence adherencetooralanticancerchemotherapywhatinfluencespatientsoverornonadherenceanalysisoftheoctostudythroughquantitativequalitativemethods AT guittonjerome adherencetooralanticancerchemotherapywhatinfluencespatientsoverornonadherenceanalysisoftheoctostudythroughquantitativequalitativemethods AT girardpascal adherencetooralanticancerchemotherapywhatinfluencespatientsoverornonadherenceanalysisoftheoctostudythroughquantitativequalitativemethods AT freyergilles adherencetooralanticancerchemotherapywhatinfluencespatientsoverornonadherenceanalysisoftheoctostudythroughquantitativequalitativemethods AT todmichel adherencetooralanticancerchemotherapywhatinfluencespatientsoverornonadherenceanalysisoftheoctostudythroughquantitativequalitativemethods AT rioufolcatherine adherencetooralanticancerchemotherapywhatinfluencespatientsoverornonadherenceanalysisoftheoctostudythroughquantitativequalitativemethods AT trilletlenoirveronique adherencetooralanticancerchemotherapywhatinfluencespatientsoverornonadherenceanalysisoftheoctostudythroughquantitativequalitativemethods AT chauvinfranck adherencetooralanticancerchemotherapywhatinfluencespatientsoverornonadherenceanalysisoftheoctostudythroughquantitativequalitativemethods |